drugset / Trial / NCT01308749

A Study of Oxytocin in Children and Adolescents With Autistic Disorder

NCT01308749

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators propose to conduct this pilot study to evaluate oxytocin as a supplemental treatment for improving social difficulties in individuals with autism.

Timeline

Start
2011-03
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 24 iu Intranasal
Comparator Oxytocin Peptide 32 iu Intranasal

Indications